• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 SWATH 质谱获得的蛋白质组型的乳腺癌分类。

Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry.

机构信息

Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czech Republic; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Department of Biology, Institute of Molecular Systems Biology, Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA.

出版信息

Cell Rep. 2019 Jul 16;28(3):832-843.e7. doi: 10.1016/j.celrep.2019.06.046.

DOI:10.1016/j.celrep.2019.06.046
PMID:31315058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6656695/
Abstract

Accurate classification of breast tumors is vital for patient management decisions and enables more precise cancer treatment. Here, we present a quantitative proteotyping approach based on sequential windowed acquisition of all theoretical fragment ion spectra (SWATH) mass spectrometry and establish key proteins for breast tumor classification. The study is based on 96 tissue samples representing five conventional breast cancer subtypes. SWATH proteotype patterns largely recapitulate these subtypes; however, they also reveal varying heterogeneity within the conventional subtypes, with triple negative tumors being the most heterogeneous. Proteins that contribute most strongly to the proteotype-based classification include INPP4B, CDK1, and ERBB2 and are associated with estrogen receptor (ER) status, tumor grade status, and HER2 status. Although these three key proteins exhibit high levels of correlation with transcript levels (R > 0.67), general correlation did not exceed R = 0.29, indicating the value of protein-level measurements of disease-regulated genes. Overall, this study highlights how cancer tissue proteotyping can lead to more accurate patient stratification.

摘要

准确的乳腺癌分类对于患者管理决策至关重要,并能够实现更精确的癌症治疗。在这里,我们提出了一种基于序贯窗口采集所有理论碎片离子谱(SWATH)质谱的定量蛋白质组学方法,并确定了用于乳腺癌分类的关键蛋白质。该研究基于代表五种传统乳腺癌亚型的 96 个组织样本。SWATH 蛋白质组型模式在很大程度上再现了这些亚型;然而,它们也揭示了传统亚型内的异质性,三阴性肿瘤的异质性最高。对蛋白质组型分类贡献最大的蛋白质包括 INPP4B、CDK1 和 ERBB2,并且与雌激素受体(ER)状态、肿瘤分级状态和 HER2 状态相关。尽管这三个关键蛋白质与转录水平具有很高的相关性(R>0.67),但总体相关性不超过 R=0.29,表明疾病调节基因的蛋白质水平测量具有价值。总的来说,这项研究强调了癌症组织蛋白质组学如何能够实现更准确的患者分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/24b037e65781/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/919ba6f63fca/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/5405ba837934/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/2d8f3c6d8405/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/7287f1f7d0db/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/cf8a0adff6d7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/5011b8570572/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/24b037e65781/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/919ba6f63fca/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/5405ba837934/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/2d8f3c6d8405/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/7287f1f7d0db/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/cf8a0adff6d7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/5011b8570572/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b4/6656695/24b037e65781/gr6.jpg

相似文献

1
Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry.基于 SWATH 质谱获得的蛋白质组型的乳腺癌分类。
Cell Rep. 2019 Jul 16;28(3):832-843.e7. doi: 10.1016/j.celrep.2019.06.046.
2
High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratification.乳腺癌亚型的高通量蛋白质组学:生物学特征及用于患者分层的多个候选生物标志物组
J Proteomics. 2023 Aug 15;285:104955. doi: 10.1016/j.jprot.2023.104955. Epub 2023 Jun 28.
3
Protein Corona Gold Nanoparticles Fingerprinting Reveals a Profile of Blood Coagulation Proteins in the Serum of HER2-Overexpressing Breast Cancer Patients.蛋白冠金纳米颗粒指纹图谱揭示了 HER2 过表达乳腺癌患者血清中的凝血蛋白特征。
Int J Mol Sci. 2020 Nov 10;21(22):8449. doi: 10.3390/ijms21228449.
4
Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.多管齐下的定量蛋白质组学揭示了乳腺癌内在亚型中的血清蛋白质组改变。
J Proteomics. 2017 Jun 23;163:1-13. doi: 10.1016/j.jprot.2017.05.007. Epub 2017 May 8.
5
SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.SWATH质谱技术应用于脑脊液差异蛋白质组学:一种样本特异性方法的建立
Methods Mol Biol. 2019;2044:169-189. doi: 10.1007/978-1-4939-9706-0_11.
6
Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics.多管齐下的定量蛋白质组学揭示HER2富集型乳腺癌中的尿液蛋白质组改变
Proteomics. 2016 Sep;16(17):2403-18. doi: 10.1002/pmic.201600015. Epub 2016 Aug 5.
7
Quantification of Breast Cancer Protein Biomarkers at Different Expression Levels in Human Tumors.人类肿瘤中不同表达水平的乳腺癌蛋白质生物标志物的定量分析。
Methods Mol Biol. 2018;1788:251-268. doi: 10.1007/7651_2017_113.
8
Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry.应用“所有理论碎片离子质谱的顺序窗口采集”(SWATH)结合液相色谱-高分辨率串联质谱进行系统毒理学分析。
Anal Bioanal Chem. 2015 Jan;407(2):405-14. doi: 10.1007/s00216-014-8262-1. Epub 2014 Nov 1.
9
Next Generation Proteomics for Clinical Biomarker Detection Using SWATH-MS.使用SWATH-MS进行临床生物标志物检测的新一代蛋白质组学
Methods Mol Biol. 2019;1977:3-15. doi: 10.1007/978-1-4939-9232-4_1.
10
Optimization of Acquisition and Data-Processing Parameters for Improved Proteomic Quantification by Sequential Window Acquisition of All Theoretical Fragment Ion Mass Spectrometry.通过全理论碎片离子质谱的顺序窗口采集优化采集和数据处理参数以改进蛋白质组定量分析
J Proteome Res. 2017 Feb 3;16(2):738-747. doi: 10.1021/acs.jproteome.6b00767. Epub 2017 Jan 3.

引用本文的文献

1
Characterization of the AGR2-NPM3 axis uncovers the AGR2 involvement in PD-L1 regulation in colorectal cancer.鉴定 AGR2-NPM3 轴揭示了 AGR2 在结直肠癌中 PD-L1 调控中的作用。
Sci Rep. 2024 Sep 20;14(1):21926. doi: 10.1038/s41598-024-72990-z.
2
Identification of plasma proteomic signatures associated with the progression of cardia gastric cancer and precancerous lesions.与贲门胃癌及癌前病变进展相关的血浆蛋白质组学特征的鉴定
J Natl Cancer Cent. 2023 Oct 19;3(4):286-294. doi: 10.1016/j.jncc.2023.10.003. eCollection 2023 Dec.
3
A hybrid DDA/DIA-PASEF based assay library for a deep proteotyping of triple-negative breast cancer.
基于杂交 DDA/DIA-PASEF 的三重阴性乳腺癌深度蛋白质组分析检测库。
Sci Data. 2024 Jul 18;11(1):794. doi: 10.1038/s41597-024-03632-2.
4
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling.蛋白质组学分析显示,ESR1 突变增强了细胞周期蛋白依赖性激酶信号通路。
Sci Rep. 2024 Mar 22;14(1):6873. doi: 10.1038/s41598-024-56412-8.
5
MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype.微小RNA作为基底样乳腺癌亚型特征的分子生物标志物
Biomedicines. 2023 Nov 9;11(11):3007. doi: 10.3390/biomedicines11113007.
6
Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges.液体活检中癌症生物标志物发现的多组学方法:进展与挑战
Biomark Insights. 2023 Oct 14;18:11772719231204508. doi: 10.1177/11772719231204508. eCollection 2023.
7
Omics-Based Investigations of Breast Cancer.基于组学的乳腺癌研究。
Molecules. 2023 Jun 14;28(12):4768. doi: 10.3390/molecules28124768.
8
Proteomics-Based Identification of Dysregulated Proteins and Biomarker Discovery in Invasive Ductal Carcinoma, the Most Common Breast Cancer Subtype.基于蛋白质组学鉴定浸润性导管癌(最常见的乳腺癌亚型)中失调的蛋白质并发现生物标志物
Proteomes. 2023 Apr 3;11(2):13. doi: 10.3390/proteomes11020013.
9
Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer.激素受体阳性乳腺癌的遗传学、治疗及新技术
Cancers (Basel). 2023 Feb 18;15(4):1303. doi: 10.3390/cancers15041303.
10
Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer.儿茶酚-O-甲基转移酶抑制细胞侵袭,并与雌激素依赖性乳腺癌中的 MET 信号相互作用。
Sci Rep. 2023 Jan 23;13(1):1285. doi: 10.1038/s41598-023-28078-1.